More Than Just Risk: Genetic Testing Is Shaping Breast Cancer Treatment

https://investor.myriad.com/news-releases/news-release-detail/19906/

Myriad and Pfizer Build Upon a Previously Announced Companion ...

... BRCA1 and BRCA2 genes using genomic DNA obtained from whole blood specimens collected in EDTA. Single nucleotide variants and small insertions and deletions ...

https://investor.myriad.com/news-releases/news-release-detail/11731/

Three New Myriad Studies Highlighted at 2014 San Antonio Breast ...

Dec 9, 2014 ... The myRisk Hereditary Cancer test found BRCA1 ... Myriad's BRACAnalysis is a molecular diagnostic test for identifying germline (hereditary) ...

https://myriad.com/genetic-tests/myrisk-germline-test/

MyRisk® Germline Test for Cancer Treatment - Myriad Genetics

Did you know that up to 10% of germline variants are missed by tumor testing alone?² The MyRisk Test identifies germline BRCA1/2 variants that may impact use of ...

https://investor.myriad.com/news-releases/news-release-detail/19261/

Myriad Receives Pre-Market Approval for its BRACAnalysis ...

Apr 2, 2018 ... "Breast cancer doctors in Japan can offer BRACAnalysis to their patients with metastatic breast cancer to determine if the carry germline BRCA1 ...

https://myriad.com/myriad.../heidi-believes-in-the-value-of-genetic-testing/

Heidi Believes in the Value of Genetic Testing - Myriad Genetics

Oct 22, 2014 ... ... BRCA1 positive as well. Because of this, my sister was convinced to get tested. She also is positive for the BRCA1 mutation. However ...

https://investor.myriad.com/news-releases/news-release-detail/27106/

Myriad Genetics Receives FDA Approval of the MyChoice CDx Test ...

The test determines HRD status by leveraging next generation sequencing technology to conduct a comprehensive assessment of BRCA1/2 genes -- including large ...

https://investor.myriad.com/news-releases/news-release-detail/11836/

Myriad Showcases Its Pioneering Research at the 2015 ASCO ...

May 13, 2015 ... Title: Association of tumor BRCA1 reversion mutation arising during neoadjuvant platinum-based therapy in breast cancer (BC) with therapy ...

https://investor.myriad.com/news-releases/news-release-detail/10921/

AstraZeneca Advances PARP Inhibitor Into Phase 3 Trial With ...

Jun 1, 2013 ... BRACAnalysis is a genetic test that confirms the presence of a BRCA1 or BRCA2 gene mutation. BRCA mutations are responsible for the majority ...

https://myriad.com/.../addressing-provider-misconceptions-in-ovarian-canc...

Addressing Provider Misconceptions in Ovarian Cancer Genetic ...

Sep 30, 2025 ... ... BRCA1/2. About 15% of ovarian cancer patients carry germline BRCA1/2 mutations, with another 5–7% carrying somatic (tumor) BRCA mutations.⁴ ...

https://investor.myriad.com/news-releases/news-release-detail/23106/

News Release - Investor relations - Myriad Genetics

May 26, 2022 ... ... BRCA1. “Cancer prevention and treatment are most effective when informed by genetic insights,” said Thomas Slavin, M.D., chief medical ...